Browse Databases and Tools

Sort by Show per page
  • Rosacea
    EBMG Guidelines, 30-May-2017
  • Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
    EBMG Guidelines, 8-Sep-2017
  • Sarcoidosis
    EBMG Guidelines, 21-Mar-2017
  • Sarcomas
    EBMG Guidelines, 25-Jul-2017
  • Scabies
    EBMG Guidelines, 6-Sep-2017
  • Scalp problems
    EBMG Guidelines, 24-May-2017
  • Schistosomal dermatitis
    EBMG Guidelines, 28-Feb-2017
  • Schistosomiasis (bilharziasis)
    EBMG Guidelines, 28-Feb-2017
  • Schizophrenia
    EBMG Guidelines, 25-Aug-2017
  • Scoliosis and kyphosis
    EBMG Guidelines, 24-Jan-2017
  • Screening and prevention of colorectal cancer
    EBMG Guidelines, 28-Mar-2017
  • Screening for fetal chromosomal abnormalities
    EBMG Guidelines, 2-May-2017
  • Seborrhoeic dermatitis
    EBMG Guidelines, 26-May-2017
  • Secondary anaemia
    EBMG Guidelines, 3-Sep-2017
  • Secondary hypertension
    EBMG Guidelines, 7-Mar-2017
  • Selective mutism
    EBMG Guidelines, 13-Oct-2009
  • Septicaemia
    EBMG Guidelines, 7-Aug-2013
  • Sequelae of traumatic brain injury
    EBMG Guidelines, 16-Jun-2014
  • Severe infections of the skin and soft tissues
    EBMG Guidelines, 26-May-2017
  • Shunt complications in children
    EBMG Guidelines, 6-Sep-2016
[x]

Login or Subscribe

Login

Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More